Long-term complete response to gefitinib after treatment termination in a patient with recurrent post-operative EGFR-mutated lung adenocarcinoma: case report and literature review

Non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations is highly sensitive to EGFR-tyrosine kinase inhibitor (EGFR-TKI). However, few cases of advanced NSCLC completely cured by EGFR-TKIs have been reported. We present an extremely rare case of lung adenocarcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Kenji, Haratake, Naoki, Takenaka, Tomoyoshi, Nagano, Taichi, Oku, Yuka, Kosai, Keisuke, Ono, Yuki, Kohno, Mikihiro, Oda, Yoshinao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798613/
https://www.ncbi.nlm.nih.gov/pubmed/35116352
http://dx.doi.org/10.21037/tcr-21-1140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798613/
https://www.ncbi.nlm.nih.gov/pubmed/35116352
http://dx.doi.org/10.21037/tcr-21-1140

Ejemplares similares